nichel, and the French Study Group for Oocyte Donation* Context: Recombinant human GH treatment and oocyte donation (OD) have improved the quality of life in women with Turner syndrome (TS). However, life expectancy is reduced, mainly due to cardiovascular complications. Pregnancy may itself increase that risk and be associated with hazardous materno-fetal outcome.
T urner syndrome (TS) is the most common gonadal dysgenesis in women. It occurs in 0.2% of female fetuses, but most of them are lost due to major cardiovascular defects (1, 2) . Its prevalence is about one in 2000 liveborn girls (3) . TS results from complete or partial loss of one X chromosome with or without cell-line mosaicism or linked to an abnormal X chromosome. TS in its classical form is associated with short stature, hypogonadism, and polymalformations (cardiac, renal, and skeletal). Haploinsufficiency of X pseudo-autosomal genes that are involved in the development and maintenance of the ovarian follicle pool leads to an acceler-ation of follicular atresia and in most cases to gonadal failure with primary amenorrhea. Achieving spontaneous puberty and pregnancy is rare in TS, occurring in only 5 and 2% of cases, respectively (4, 5) .
The use of recombinant human GH (hGH) and the advent of oocyte donation (OD) in case of ovarian insufficiency have improved the quality of life of TS women (6) . However, life expectancy seems in TS to be reduced by more than 10 yr (7) (8) (9) . Cardiovascular complications including cardiovascular defects, systemic hypertension, myocardial ischemia, and aortopathy are the main cause of increased mortality in this syndrome (10, 11) . Congenital cardiac abnormalities are described in 50 -75% of cases (12) , the most common of which are bicuspid aortic valve and aortic root coarctation or dilatation (7, (13) (14) (15) (16) . The prevalence of hypertension is increased in both girls and women with TS (17) , and myocardial ischemia is twice as frequent (9, 10) . But the greatest excess risk remains dissection or rupture of the aorta, which accounts for death in 2-8% of women with TS (18, 19) . This aortic disease has been considered to mimic the traits described in Marfan syndrome characterized by cystic medial necrosis (20) . Aortic dissection remains incompletely understood and might involve either jugular lymphatic obstruction and/or an Xp haploinsufficient gene related to connective tissue (21) . Dilatation of the aortic root, a bicuspid aortic valve, and hypertension are considered as classical predisposing factors for aortic dissection or rupture (22, 23) .
More recently, pregnancy has risen in TS as an additive risk factor (24 -26) as already observed in Marfan syndrome (27) . In fact, since the successful use of OD in in vitro fertilization for women with premature ovarian failure (28) , OD has brought new hope to TS patients whose fertility prognosis seems to have completely changed. Pregnancy rates after OD in patients with TS are reportedly quite similar to those among other women (29 -31) despite higher rates of miscarriages (4, 29) . However, concerning the obstetrical outcome, only limited data and small cohorts (29, 30, 32) are available. Nagel and Tesch (26) was the first to report two maternal deaths by aortic dissection after OD in TS. An American survey published in 2003 (25) calculated a higher risk of death during pregnancy from aortic rupture or dissection in women with TS, based on the report of four fatal cases of aortic dissection in the literature during their study, between 1999 and 2003, including the two cases previously reported by Nagel and Tesch (26) . Bodri et al. (32) reported in 2006 nine pregnancies after OD in women with TS, with mild or severe maternal hypertension in five patients, including one eclampsia leading to fetal demise.
More recently, two other cases of maternal death by aortic dissection after OD in women with TS and one case of eclampsia with an acute cardiac failure in a twin pregnancy have been reported in France (33) (34) (35) . These data led the Biomedical Agency to invite French Medical Societies to elaborate recommendations for such highrisk pregnancies. We therefore conducted a multicentric, retrospective study on TS pregnancies beyond 20 wk gestation to evaluate the materno-fetal outcome. were retrospectively asked about pregnancies obtained after OD in women with TS since they began their OD practice (1991 for two centers; later for the others). The questionnaire (available on request) consisted of checkbox-style questions designed to facilitate responses; accompanying the questionnaire was a letter explaining the study and assuring the respondents of anonymity. Nineteen of 24 habilitated centers in France usually performed OD; all of them answered and completed all or part of the items. These data concerned a total of 93 pregnant patients with TS who received OD between January 1991 and June 2009 and developed ongoing pregnancies beyond 20 wk gestation. We estimate that this cohort represents nearly all and in any case more than 90% of the ongoing pregnancies that have ever occurred after OD in TS recipients in the French centers since 1991.
Patients and Methods

Patients
Oocyte donation
OD was performed according to French bioethics laws (1994, 2004) . Donation was anonymous and altruistic and made after a delay of 6 months for reflection. Embryo replacement was performed before 43 yr of age. Protocol of endometrial preparation of recipients was available on request and combined oral estradiol with micronized vaginal progesterone. The mean age of the donors at time of OD was 30.9 Ϯ 4.3 yr (range, 21-38 yr).
All recipients benefited from a careful clinical assessment including general physical and gynecological examination, blood tests (serology), and assessment of the uterine cavity by ultrasonography and either hysterosalpingography or hyster-oscopy to measure uterus, to evaluate endometrium, and to detect major abnormalities. TS recipients were besides screened for hypothyroidism (n ϭ 10) and pregestational diabetes (n ϭ 1) and also treated if necessary; due to the lack of specific recommendations until recently, cardiological evaluation including echocardiography, thoracic magnetic resonance imaging (MRI), and/or blood pressure screening were performed according to the experience of the practitioner in charge of the patients.
Obstetrical outcome
Ongoing pregnancy was defined as a viable pregnancy confirmed by ultrasonography performed at 20 wk pregnancy. Pregnancy-induced hypertension (PIH) was defined as new onset of hypertension with two readings at least 6 h apart of more than 140 mm Hg systolic or more than 90 mm Hg diastolic after 20 wk pregnancy. Preeclampsia (PE) was defined as PIH together with proteinuria confirmed on urine collection (Ͼ300 mg/24 h). Fetal death was considered an intrauterine fetal death after 20 wk pregnancy. Gestational diabetes was diagnosed by a universal two-step screening strategy according to French recommendations: O'Sullivan test with a threshold of 130 mg/dl followed by a 100-g oral glucose tolerance test if positive (36) .
Term and modality of delivery were recorded, as were anthropometric data of newborns. Birth weight was expressed in centiles after adjustment for the number of fetuses, newborn gender, birth rank, and maternal weight according to local standards (37) .
Statistical analysis
All data were analyzed using EXCEL (Microsoft Corp., Redmond, WA) and STATVIEW5 (SAS Institute Inc., Cary, NC) software. Data are expressed as mean Ϯ SD and percentages. Comparisons between groups were performed using Student's t test. Cutoff points were determined by a 2 automatic interaction detection algorithm or using Fisher's exact test in case of larger cross-tabulations. All probabilities were two sided, with a P value Ͻ0.05 considered statistically significant.
Results
Patients
Characteristics of the patients are displayed in Table 1 . TS had been diagnosed at the mean (Ϯ SD) age of 17.9 Ϯ 8.8 yr (range, 0 -38 yr) because of gonadal failure with primary amenorrhea except two cases of neonatal diagnosis and three cases of infantile diagnosis (according to malformations and growth retardation).
Percentages of Turner patients with preexisting cardiological abnormalities were low because data were incomplete for several patients. Indeed, pregravid cardiological check-up was known in only 56 patients (60.2%); echocardiography was performed in 31 patients (33.3%) and thoracic MRI in only four (4.3%). Aortic diameter was evaluated in only six patients (6.4%).
Oocyte donation
Each recipient had a pelvic ultrasonography that showed a bicornuate uterus in four cases and a hypoplastic uterine cavity in one case; these abnormalities did not dissuade OD. Mean endometrial thickness at embryo replacement day was normal and measured at 9.9 Ϯ 2.0 (5.5-16.7) mm. Single-embryo transfer was performed in 29 patients (40%); transfer contained two embryos in 30 cases (42%) and three or more embryos in 14 cases (18%).
Pregnancies and deliveries
Maternal complications and delivery modalities are displayed in Table 2 . Thirty-one patients among 82 (37.8%) presented pregnancy-associated hypertensive disorders (PAHD), mainly severe because PE occurred in Percentages were estimated according to the global population (n ϭ 93) excepted for karyotype feature and previous treatment with hGH for which they were estimated according to the number of available data (n ϭ 72 and n ϭ 44, respectively). The three aortic root enlargements were measured above 2 cm/m 2 but lower than 2.3 cm/m 2 .
54.8% of them including one case of hemolysis, elevated liver enzymes, and low platelets syndrome and three cases of eclampsia. One eclampsia occurred at 25 wk gestation in a twin pregnancy and was associated with acute maternal cardiac failure, which improved after an emergency cesarean section allowing the rescue of the two premature newborns (34); a second case led to fetal demise at 23 wk gestation. PAHD was not related to age (P ϭ 0.88), body mass index (P ϭ 0.33), the presence of congenital cardiac abnormalities (P ϭ 0.73), or previous hGH treatment (P ϭ 1). Echocardiography was performed at least once during pregnancy in only 18 women (25%); aortic root enlargement was also reported in three (16.6%). Two of them died by aortic rupture after delivery by cesarean section at 38 wk gestation (33, 35) , determining a mortality rate of 2.2% (two of 93). The medical story of the first patient has been previously reported (33) . She was 33 yr old and was diagnosed for bicuspid aortic valve associated with aortic root dilation (39 mm) at the second trimester of pregnancy. Aortic dissection was diagnosed at 38 wk gestation, requiring emergency cesarean delivery and immediate aortic root replacement that could not prevent early postsurgical death (33) . The second, a 33-yr-old woman, died 7 d after a cesarean section performed at 38 wk gestation for materno-fetal disproportion and gravidic cholestasis. The autopsy revealed a massive hemopericardium with a dissection of the aortic root (35) . Preconceptional echocardiographic evaluation was also considered normal despite a grade 1 aortic insufficiency; the echocardiography performed at 6 months of gestation noticed an aortic dilatation (35 mm). The third case of aortic root enlargement was reported without poor obstetrical outcome but had neither aortic valve abnormality nor PAHD.
Twin pregnancies occurred in eight patients of 93 achieved pregnancies (8.6%). PAHD seems to be more frequent in this specific group, but no significant statistical difference was observed according to the small number of twin pregnancies in our cohort (50.0 vs. 36.5%; P ϭ 0.46). One patient developed eclampsia with acute maternal cardiac failure like described above; another one developed acute twin-twin transfusion syndrome in a monochorionic pregnancy, leading to the death of both twins at 27 wk gestation. Mean birth weight (Table 3 ) and mean gestational age at delivery (35.0 vs. 35.6 wk gestation) was significantly lower in these pregnancies (P Ͻ 0.0001 and P ϭ 0.02, respectively). Percentages were calculated for patients with complete data (n ϭ 82 for pregnancy, and n ϭ 71 for delivery) except for maternal mortality rate estimated according to the global population (n ϭ 93). PIH was defined as new onset of hypertension with two readings at least 6 h apart higher than 140 mm Hg systolic or higher than 90 mm Hg diastolic after 20 wk pregnancy. PE was defined as PIH together with proteinuria confirmed on urine collection (Ͼ300 mg/24 h). HELLP, Hemolysis, elevated liver enzymes, and low platelets. 
Neonatal outcome
Eighty-two patients gave birth to 87 healthy infants (three fetal demises). Characteristics of the newborns and specific neonatal complications are displayed in Table 3 . Prematurity rate was high (38.3%) and mainly correlated to PE [56.0 vs. 24.4; odds ratio ϭ 3.945 (95% confidence interval ϭ 1.36 -11.4); P ϭ 0.01]. Frequencies of intrauterine growth retardation (IUGR) and severe IUGR (below the 10th percentile and below the 3rd percentile, respectively) were estimated to be 27.5 and 13.7% after adjustment according to local standards (37), which was possible for 51 newborns. No macrosomia was described in our cohort of newborns.
Discussion
The development of recombinant hGH treatment and successful OD in ovarian failure have led to rather optimistic views concerning the quality of life in young girls with TS. However, at the same time, it has become increasingly documented that this syndrome is associated with increased morbidity and mortality, mostly due to cardiovascular complications, including cardiac malformations, early-onset hypertension, coronary ischemia, and aortic dissection and rupture (10, 11) . Because pregnancies are easily available through OD, an important question for TS women is whether the obstetrical outcome would be particularly deleterious for these patients. Although the first successful OD was published in 1984 (28) , only a few reports of pregnancies obtained in TS by OD have concerned materno-fetal outcome. Several case reports of maternal deaths by dilatation and rupture of aortic root have, however, been published since 1997, and a recent study of nine pregnancies indicated a high frequency of hypertension (32) . Our retrospective, multicentric study is so far the first study clearly showing that pregnancies obtained by OD in TS are very high-risk pregnancies with two major cardiovascular maternal risks: aortic rupture and PE with its fetal consequences (prematurity, fetal stress, and IUGR).
With an incidence estimated to be 1.4% (38) , the risk for acute aortic dissection is known to be increased in TS by more than 100-fold in young and middle-aged women with a mean age at occurrence of 31 yr, which is much younger than in other aortic dissections (mean age of 68 yr) (24, 38) . Bicuspid aortic valve, aortic coarctation, and systemic hypertension are classical risk factors, which could act as mechanical factors. However, aortic dilatation seems to be relatively frequent in TS even when aortic diameter is normalized to body surface area (aortic size index) (21) . Pregnancy likely represents an additive risk factor that has risen only recently (24) with the increasing number of TS women becoming pregnant through OD. In our exhaustive retrospective study of about 20 yr including all French centers performing OD, we reported 93 pregnancies and two cases of aortic dissection. In a retrospective telephone study, Karnis et al. (25) obtained answers from only half of the American centers, allowing them to collect 101 achieved pregnancies, and indicated four cases of aortic dissection in the United States according to a literature review. In the recent review of Carlson and Silberbach (24) , aortic dissection occurred during or just after pregnancies in six of 85 cases reported (Table 4) ; this was fatal in six of eight cases, suggesting that pregnancy is a major risk factor. Moreover, 60% of aortic dissections from any cause for women of reproductive age are estimated to occur in late pregnancy (39) . Thus, pregnancy could be an independent risk factor for aortic dissection because the increase of cardiac output and volume (40, 41) , the estrogenic elevation, and the thirdtrimester hypertension could accelerate the weakening of aortic wall. In contrast, we did not observe a correlation between hGH pretreatment and aortic dilatation or rupture; this lack of correlation has also been previously reported (42) . Moreover, recent data support in TS a primary disorder of the composition of the aortic wall, with intimal-medial thickening and vessel dilatation, diffusely in the vasculature, including the aorta. Histological findings with aortic cystic medial necrosis such as in Marfan syndrome (43, 44) have been reported in women with TS even in the absence of coronary heart disease (23), suggesting a connective tissue disorder of genetic origin and possible arterial impaired TGF-␤ signaling (20, 45) . The New York Heart Association reports that women with Marfan syndrome have a maternal mortality rate of 5-15% when the aorta seems normal and 25-50% for those with aortic dilatation already (46) ; the cause of death was also aortic root dissection or rupture. Because hypertension constitutes a major risk factor for aortic dissection, vigorous treatments have been recently proposed in Marfan syndrome to prevent aortic dilatation (47) .
In TS, hypertension is a well-known complication because it occurs in more than half of TS patients and begins early in life, illustrated by the loss of the circadian rhythm when explored (17, 45) . In our retrospective study, this recently recommended exploration had never been performed, explaining that only one patient was clearly defined as hypertensive before pregnancy. The second main result of our study is that PAHD occurs in about four of 10 pregnancies. The question is to determine whether this increase of PAHD is linked to OD itself only or associated with specific risk linked to TS. In fact, on one hand, maternal hypertension has been regularly reported to be associated with OD independently of the cause of ovarian failure (48 -50) . Advanced maternal age, high rate of multiple pregnancies, or impaired development of the materno-fetal immunotolerance due to the lack of maternal antigens have been suggested (48) . On the other hand, TS involves risk factors such as pregravid hypertension, arteriopathy, congenital cardiac defects, age, obesity, and/or insulin resistance, which may all contribute to PAHD. In our cohort, mean age at OD and body mass index were not different between patients with or without PAHD; PAHD seems to be less frequent in case of hGH pretreatment, although the difference was not significant. Hypoplastic uterus was present in one patient and could also represent an additional risk factor. Thus, the shared responsibility of TS and OD is difficult to discriminate. Both are probably involved. Only a prospective control study with agematched groups would be able to precisely determine their own responsibilities. Nevertheless, PAHD have severe materno-fetal consequences and were related in our cohort to one fetal demise, three eclampsia, and an emergency cesarean section at 25 wk gestation for acute cardiac failure, with a very high rate of prematurity (38.3%) and IUGR (27.5%).
In this retrospective but exhaustive multicenter study, we demonstrated with a large cohort covering a period of about 20 yr, during which no specific recommendations were available, that pregnancies obtained after OD in TS were very high-risk pregnancies because only 40.2% of our pregnancies were achieved without any complication. We noticed especially an increased risk of maternal death by aortic dissection or rupture (two of 93) and high PAHD frequency (37.8%) with its materno-fetal complications. Recommendations have been recently proposed by several scientific societies (16, 25, 51, 52 ) for a specific prepregnancy screening including 1) echocardiography, thoracic MRI with precise aortic measures, and overnight blood pressure monitoring; 2) precise contraindications (untreated hypertension, previous aortic coarctation or dissection, and aortic size index Ͼ25 mm/m 2 ); and 3) exclusive single-embryo transfer, associated with an intensive cardiological follow-up in an adapted care center and with an aggressive hypertensive treatment. In the future, prospective studies will indicate whether the respect of these recent recommendations will effectively be able to improve the materno-fetal outcome of pregnancies obtained in TS after OD, which must meanwhile still be considered as very high-risk pregnancies.
